Module II
Cardiology
FEB 27-29, 2020 - Los Angeles, CA
Register Now
Description
Module II: Cardiology will highlight clinical cardiovascular information, through an overview of didactic learning, case studies, clinical applications, therapeutic guidelines, and extensive faculty interaction with top-tier practicing clinicians. Attendees will not only learn the most clinically current research in the field of cardiovascular health, but also understand best practices & protocols for applying educational concepts to other forms of metabolic disease. Sessions will review the causes and mechanisms of hypertension, diabetes, coronary artery disease, and metabolic syndrome, in addition to how the conditions are interrelated and connected. The module will also assess various methods of diagnosis, evaluation, and treatment, coupled with an assessment of laboratory evaluations, nutritional treatments, and lifestyle recommendations. Lectures will additionally emphasize the treatment modalities available for hypercholesterolemia, hyperinsulinemia, and hypertriglyceridemia, along with abnormal cholesterol fractionation results through a hands-on, case history format.
Register
Learning Objectives
- Understand the role of endothelial dysfunction, nitric oxide, angiotensin II and aldosterone in atherosclerosis, CHD and CVD
- Understand how inflammation, oxidative stress and vascular immune dysfunction promote CVD and CHD
- Be familiar with the pathways of vascular aging, pathogenesis, and how they relate to the prevention and treatment of atherosclerosis, CHD and CVD
- Review the underlying causes and mechanisms of dyslipidemia and dyslipidemia-induced cardiovascular disease
- Understand and apply advanced lipid testing (lipid particle number and size and HDL functionality and quality) for the diagnosis and treatment of dyslipidemia in clinical practice
- Present, review and discuss clinical cases on hypertension, dyslipidemia, CHD and CVD
- Measure the three finite vascular responses (inflammation, oxidative stress and vascular immune function), plasma renin activity (PRA) and aldosterone to select optimal integrative anti-hypertensive therapy to reduce BP and decrease CVD
- Understand the role of vascular biology in atherosclerosis vascular disease, CHD and CVD
- Review and understand the role of the microbiome in CVD
- Review and understand the role of insulin resistance, obesity, inflammation, and diabetes in CVD
- Review and understand drug-nutrient reactions and interactions in CVD
- Review how the microbiome induces Cardiovascular disease and inflammation and importance of Diversity
- Discuss how the microbiome may influence metabolic endotoxemia
- Identify which organism is associated with cardiovascular disease and metabolic syndrome
- Learn how to assess the microbiome
- Discuss treatments to improve microbiome health
Event Schedule
Thursday, February 27, 2020
7:30 am
Vascular Biology and Cardiovascular Disease for the Clinician with Case Presentations and Clinical Pearls
Mark Houston, MD, MS, MSc
9:30 am
Break
10:00 am
Cardiovascular Aging, Pathophysiology, Clinical Evaluation, Telomeres and Cardiovascular Disease for the Clinician with Case Presentations and Clinical Pearls
Mark Houston, MD, MS, MSc
12:00 pm
Lunch
Sponsored by Fortune Firm
1:30 pm
Nutrition and Cardiovascular Disease: Scientific Clinical Review of the Trials with Clinical Application and Case Presentations
Deanna Minich PhD
3:30 pm
Break
4:00 pm
Congestive Heart Failure and Metabolic Cardiology Prevention and Treatment: An Integrative and Metabolic Medicine Approach
Douglas Harrington, MD
6:00 pm
Close of Session
Friday, February 28, 2020
7:30 am
Integrative and Metabolic Medicine Approach to Hypertension – Part 1
Mark Houston, MD, MS, MSc
9:30 am
Break
10:00 am
Integrative and Metabolic Medicine Approach to Hypertension – Part 2
Mark Houston, MD, MS, MSc
11:00 am
Type 2 Diabetes Mellitus: Pathophysiology, Diagnosis, Prevention and Treatment – Part 1
Filomena Trindade, MD
12:00 pm
Lunch
Sponsored by Bio-Botanical
1:30 pm
Type 2 Diabetes Mellitus: Pathophysiology, Diagnosis, Prevention and Treatment – Part 2
Filomena Trindade, MD
2:30 pm
Clinical Integrative Management of Dyslipidemia and Dyslipidemia-induced Cardiovascular Disease and Atherosclerosis – Part 1
Mark Houston, MD, MS, MSc
3:30 pm
Break
4:00 pm
Clinical Integrative Management of Dyslipidemia and Dyslipidemia-induced Cardiovascular Disease and Atherosclerosis – Part 2
Mark Houston, MD, MS, MSc
6:00 pm
Close of Session
Saturday, February 29, 2020
7:00 am
Clinical Integrative Management of Dyslipidemia and Dyslipidemia-induced Cardiovascular Disease and Atherosclerosis – Part 3
Mark Houston, MD, MS, MSc
8:00 am
Coronary Heart Disease and Myocardial Infarction Prevention and Treatment: An Integrative and Metabolic Medicine Approach – Part 1
Mark Houston, MD, MS, MSc
9:00 am
Break
9:30 am
Coronary Heart Disease and Myocardial Infarction, Prevention and Treatment: An Integrative and Metabolic Medicine – Part 2
Mark Houston, MD, MS, MSc
11:30 am
Lunch
1:00 pm
The Role of the Microbiome and the GI tract in Cardiovascular Disease with Clinical Case Presentations
Jill Carnahan, MD
3:00 pm
Break
3:30 pm
Personalized and Precision Cardiovascular Medicine, Cardiovascular Nutragenomics and Genetics for the Clinician with Clinical Cases, Putting it all Together for Your Clinical Practice
Mark Houston, MD, MS, MSc
5:30 pm
Close of Session
Register Today!
Terranea Resort
100 Terranea Way
Rancho Palos Verdes, CA 90275
Exclusive Room Rate: $265
Expires: Feb 5, 2020
Save on your airfare by flying with Delta Airlines. Mention Code NMSTM and receive anywhere from a 3%-10% discount depending on class.
